Salera, Maris .
HRN: 22-42-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2023
CEFTRIAXONE 1G (VIAL)
01/07/2023
01/14/2023
2 G
IVT
Q24 H
S/P Pelvic Laparotomy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes